Financials
- Market Capitalization 12.38 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 708 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 238.05 USD | +0.46% | -3.84% | +3.11% | +70.04% | 14.94 B USD | ||
| 734 | EXEL Exelixis, Inc. - Common Stock | 55.77 USD | -0.48% | -1.93% | +4.56% | +42.85% | 14.02 B USD | ||
| 816 | AXSM Axsome Therapeutics, Inc. - Common Stock | 235.26 USD | +3.06% | -5.65% | -7.75% | +80.69% | 12.11 B USD | ||
| 823 | SMMT Summit Therapeutics Inc. - Common Stock | 15.47 USD | +1.11% | -1.78% | +9.56% | -22.10% | 12.01 B USD |
Frequently asked questions about Madrigal Pharmaceuticals, Inc. - Common Stock
What is the Madrigal Pharmaceuticals, Inc. - Common Stock stock price today?
The current price of Madrigal Pharmaceuticals, Inc. - Common Stock (MDGL) is 536.86. Over the past 24 hours, the stock has changed by +1.10%. Follow the MDGL chart for real-time price dynamics.
What is the stock ticker of Madrigal Pharmaceuticals, Inc. - Common Stock?
Madrigal Pharmaceuticals, Inc. - Common Stock trades under the ticker MDGL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Madrigal Pharmaceuticals, Inc. - Common Stock stock going up?
MDGL has changed by -1.03% over the last week, +6.29% over the last month, and +26.73% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Madrigal Pharmaceuticals, Inc. - Common Stock net income for the last quarter?
Madrigal Pharmaceuticals, Inc. - Common Stock reported net income of -94.39 M for the last quarter. The previous quarter showed -58.58 M, which means net income changed by -61.15%.
How many employees does Madrigal Pharmaceuticals, Inc. - Common Stock have?
As of the latest available data, Madrigal Pharmaceuticals, Inc. - Common Stock has 915 employees. Workforce size can provide additional context about the company's scale and operations.
What is Madrigal Pharmaceuticals, Inc. - Common Stock EBITDA?
Madrigal Pharmaceuticals, Inc. - Common Stock EBITDA is -92.34 M, and its EBITDA margin is -29.66%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Madrigal Pharmaceuticals, Inc. - Common Stock stock?
You can buy Madrigal Pharmaceuticals, Inc. - Common Stock (MDGL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Madrigal Pharmaceuticals, Inc. - Common Stock stock?
Investing in Madrigal Pharmaceuticals, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MDGL chart and related analysis on metatrader.com as part of your research.